Evaluation of the performance of two new generation pulse oximeters in cats at different probe positions and under the influence of vasoconstriction

评估两种新一代脉搏血氧仪在不同探头位置和血管收缩影响下对猫的性能

阅读:1

Abstract

OBJECTIVES: The aim of this study was to compare the failure rate of two new generation pulse oximeters at different probe positions, and with and without vasoconstriction, in anaesthetised cats. METHODS: This prospective clinical study included 103 cats in which the new generation pulse oximeters, the Rad-5 (Masimo) and EDAN H100N (EDAN), were evaluated. Premedication consisted of the vasoconstrictive drug combination butorphanol (0.2 mg/kg IV) and dexmedetomidine (5 µg/kg IV), or butorphanol only (0.2 mg/kg IV). Pulse oximeter failure rate at the tongue was compared between both groups. Pulse oximeter failure rate was also analysed at the alternative probe positions of the lip, pinna, knee fold and toe in the butorphanol group. Student's t-test, Wilcoxon matched pairs signed rank test, Mann-Whitney U-test, Friedman test and χ(2) test were performed. A P value <0.05 was considered to be statistically significant. RESULTS: Overall failure to achieve an adequate signal was 37.6% with the Masimo and 48.0% with the EDAN pulse oximeter (P <0.0001). At the standard probe position on the tongue, the Masimo failed in 4.5%, while the EDAN failed in 35.3% (P <0.0001). Vasoactive premedication increased the failure rate for the Masimo from 3.8% to 5.2% (P = 0.3414) and for the EDAN from 22.4% to 49.0% (P <0.0001). At the alternative probe positions of the lip and knee fold, failure rates for the Masimo were lower (39.7% and 81.4%) than with the EDAN (52.6% and 94.4%; P = 0.0231 and P = 0.0005, respectively), while the Masimo failed more often at the pinna (63.5%) than the EDAN (47.4%; P = 0.0044). At the alternative probe position of the toe, the failure rate for the Masimo (32.7%) was not different from the EDAN (38.5%; P = 0.7547). CONCLUSIONS AND RELEVANCE: The Masimo pulse oximeter had lower signal failure rates at the standard probe position on the tongue and at 2/4 alternative probe positions. The standard probe position on the tongue had the lowest failure rate for both devices. Dexmedetomidine-induced vasoconstriction increased the failure rate for the EDAN but not for the Masimo pulse oximeter.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。